The upregulated pathways, such as the renin-angiotensin system, and the downregulated pathways, such as hematopoietic cell lineage, and the changes in the PI3K-Akt signaling pathway and the PPAR signaling pathway may be the significant keys to the anti-hepatoma effects. The gene discussed is PPARA; the disease is hepatocellular carcinoma.